Ruxolitinib
APL-01
Approved small_molecule active
Quick answer
Ruxolitinib for Safety and Efficacy is a Approved program (small_molecule) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Safety and Efficacy
- Phase
- Approved
- Modality
- small_molecule
- Status
- active